A New Chapter in Global Health: WHO and Switzerland Formalize Strategic Partnership Through 2028

COPENHAGEN, Denmark – In a significant move to reinforce global health governance, the World Health Organization (WHO) and the Swiss Confederation have officially renewed their Cooperation Strategy for the 2024–2028 period. The formalization of this agreement, signed on March 4, 2025, at the WHO Regional Office for Europe in Copenhagen, marks a pivotal milestone in a partnership that has served as a global benchmark for collaboration between international health bodies and high-income nations.

The agreement solidifies a long-standing alliance, signaling a shared commitment to addressing the escalating complexities of the post-pandemic health landscape, from pandemic preparedness and digital health innovation to the strengthening of global health security architectures.

The Core Pillars of the 2024–2028 Strategy

The newly ratified WHO-Switzerland Cooperation Strategy is not merely a diplomatic formality; it is a granular roadmap designed to integrate Swiss scientific and policy expertise with the operational reach of the WHO.

At its core, the strategy focuses on four primary domains:

Global Health Governance: Leveraging Switzerland’s unique position as a neutral host for international organizations to foster consensus in health diplomacy.
Health Security and Pandemic Preparedness: Deepening the integration of the WHO BioHub system—a mechanism for the rapid sharing of pathogens and biological materials—which is headquartered in Switzerland.
Innovation and Digital Health: Harnessing Swiss research capabilities to accelerate the deployment of AI in public health surveillance and electronic health records.
Health Equity and Sustainable Systems: Ensuring that the lessons learned from the COVID-19 pandemic lead to more resilient, inclusive national health systems globally.

A Chronology of Collaboration: A Legacy of Leadership

The relationship between the WHO and Switzerland is unique, defined by geographic proximity and a shared vision for health as a pillar of human rights.

2013: The Pilot Program

The partnership traces its origins back to 2013, when Switzerland became the first high-income country within the WHO European Region to adopt a structured Country Cooperation Strategy (CCS). At the time, this was a radical shift in approach. Traditionally, the CCS model was utilized primarily for low- and middle-income countries to help define development priorities. Switzerland’s decision to pilot this framework demonstrated that even the most advanced health systems require strategic alignment with global norms to remain effective in a globalized world.

2022: The Pivot Toward Renewal

By 2022, the world had undergone a seismic shift in public health. The COVID-19 pandemic exposed vulnerabilities in global supply chains, information sharing, and institutional agility. Recognizing that the 2013 framework was insufficient for a post-2020 reality, both parties agreed that a formal renewal process was essential. This period involved extensive multi-stakeholder consultations, including the Swiss Federal Office of Public Health (FOPH) and various WHO technical departments.

2025: Formalization and Future-Proofing

On March 4, 2025, the vision became policy. Dr. Hans Henri P. Kluge, WHO Regional Director for Europe, and Barbara Schedler, Ambassador for Global Health at the Swiss Federal Office of Public Health, signed the document in Copenhagen. The signing ceremony served as a public commitment to maintain this momentum until the end of 2028, effectively setting the stage for the next four years of technical cooperation.

The Global BioHub: A Case Study in Partnership

One of the most concrete manifestations of the WHO-Switzerland relationship is the Global BioHub system. Launched in the wake of the COVID-19 pandemic, the system is designed to overcome the bottlenecks that hindered the rapid development of diagnostics, therapeutics, and vaccines during the early stages of the crisis.

The BioHub facilitates the rapid, safe, and transparent sharing of biological materials with pandemic potential between member states. By hosting the central facility, Switzerland provides the necessary legal and technical infrastructure to ensure that these materials are handled under the highest biosafety standards. This partnership has been hailed by health experts as a “critical insurance policy” for the international community, ensuring that when the next “Disease X” emerges, the global scientific community will have immediate access to the necessary data and samples.

Official Perspectives: Bridging Policy and Practice

The ceremony in Copenhagen featured remarks that underscored the strategic weight of this renewal. Dr. Hans Henri P. Kluge noted that the partnership is not just about local outcomes, but about the "multiplier effect" that Swiss participation has on the broader WHO European region and the global stage.

"Switzerland’s role extends far beyond its borders," Dr. Kluge stated. "By aligning our strategic objectives, we are creating a blueprint for how high-income nations can contribute to global health security not only through funding, but through technical leadership and policy innovation."

WHO and Switzerland cement cooperation until 2028

Ambassador Barbara Schedler emphasized that for Switzerland, the strategy is a reflection of the country’s identity as a humanitarian leader. "The challenges of the 21st century—climate change, aging populations, and antimicrobial resistance—do not respect national borders. Our partnership with the WHO is the primary vehicle through which Switzerland fulfills its commitment to multilateralism in health."

Strategic Implications: Why This Matters for Global Health

The renewal of the strategy comes at a time when the WHO is undergoing internal reforms to become more agile. The implications of this bilateral cooperation are far-reaching:

1. Strengthening Multilateralism

In an era of rising geopolitical fragmentation, the WHO-Switzerland alliance provides a stable anchor. By maintaining a clear, multi-year strategy, both entities send a signal of consistency to other member states, encouraging sustained engagement in multilateral health forums.

2. Standardizing High-Income Engagement

The success of this strategy serves as a model for other G7 and OECD nations. The WHO is currently looking to replicate aspects of this cooperation with other high-income members, aiming to move away from purely donor-recipient dynamics toward true technical partnerships.

3. Addressing Non-Communicable Diseases (NCDs)

While pandemic preparedness takes center stage, the 2024–2028 strategy also places a heavy emphasis on NCDs—the leading cause of death globally. Switzerland’s expertise in public health policy, particularly regarding tobacco control and nutrition, is being integrated into WHO’s regional programs to help combat the growing burden of heart disease, cancer, and diabetes.

4. Digital Health and Data Privacy

Switzerland is at the forefront of digital privacy and data protection, a critical issue for modern public health surveillance. The cooperation strategy outlines plans to work together on the development of ethical frameworks for the use of health data, ensuring that as digital health tools proliferate, they do not infringe on individual rights.

Supporting Data and Technical Frameworks

The 2024–2028 strategy is supported by a series of technical indicators and monitoring mechanisms. Unlike previous iterations, this version includes:

Annual Progress Reviews: Mandatory yearly evaluations conducted by a joint committee to ensure that the strategy remains adaptive to emerging crises.
Knowledge Exchange Portals: A dedicated digital infrastructure that allows Swiss academic institutions and WHO technical units to share real-time research on health system strengthening.
Resource Mapping: Clearer articulation of how Swiss technical contributions supplement WHO’s budgetary allocations, ensuring maximum efficiency and minimal duplication of efforts.

Challenges and Future Outlook

Despite the optimism surrounding the renewal, both the WHO and Switzerland acknowledge the hurdles ahead. The global health environment is increasingly volatile. Climate change is expected to drive the migration of vector-borne diseases into new territories, and the rise of antimicrobial resistance poses an existential threat to modern medicine.

Furthermore, the funding model of the WHO remains a point of intense negotiation. While this cooperation strategy provides a framework for collaboration, it relies on the continued political will of the Swiss parliament and the internal agility of the WHO’s secretariat.

However, the foundation laid by the 2013 pilot and the lessons extracted from the 2022 renewal process provide a robust platform. By 2028, the goal is not only to have met the objectives set out in the current document but to have established a permanent, institutionalized culture of collaboration that can survive political transitions and shifts in the global landscape.

As the international community grapples with the fallout of a fragmented world, the WHO-Switzerland Cooperation Strategy 2024–2028 stands as a testament to the idea that deep, strategic partnerships are the only way to safeguard the health of future generations. Through transparency, shared expertise, and a commitment to common goals, Switzerland and the WHO continue to demonstrate that when global health is prioritized, the entire world benefits.